Tune Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 13, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $175,000,000
Company Info
- Founders
- Dr. Charles Gersbach
- Company Description
- Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
- Market
- Gene, cell, and regenerative therapies
- Location
- Durham, North Carolina, USA
- Coinvestors
- Hevolution, New Enterprise Associates, Regeneron Ventures, Yosemite